Applications for new human medicines under evaluation: November 2024
Submitted by Anonymous (not verified) on 7 November 2024 - 15:54
Applications for new human medicines under evaluation: November 2024
Veterinary medicines European public assessment report (EPAR): Canigen L4, Canine leptospirosis vaccine (inactivated), Status: Authorised
Submitted by Anonymous (not verified) on 7 November 2024 - 14:48
Veterinary medicines European public assessment report (EPAR): Canigen L4, Canine leptospirosis vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Broadline, eprinomectin, fipronil, praziquantel, (S)-methoprene, Status: Authorised
Submitted by Anonymous (not verified) on 7 November 2024 - 14:37
Veterinary medicines European public assessment report (EPAR): Broadline, eprinomectin, fipronil, praziquantel, (S)-methoprene, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Bovela, bovine viral diarrhoea vaccine (modified live), Status: Authorised
Submitted by Anonymous (not verified) on 7 November 2024 - 14:20
Veterinary medicines European public assessment report (EPAR): Bovela, bovine viral diarrhoea vaccine (modified live), Status: Authorised
PSUSA/00003149/202308
Submitted by Anonymous (not verified) on 7 November 2024 - 12:53
PSUSA/00003149/202308
Summary of opinion: Metalyse, 14/12/2023 Positive
Submitted by Anonymous (not verified) on 7 November 2024 - 8:54
Summary of opinion: Metalyse, 14/12/2023 Positive
Veterinary medicines European public assessment report (EPAR): Versican Plus Pi/L4, canine parainfluenza virus and Leptospira, Status: Authorised
Submitted by Anonymous (not verified) on 6 November 2024 - 16:35
Veterinary medicines European public assessment report (EPAR): Versican Plus Pi/L4, canine parainfluenza virus and Leptospira, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Versican Plus Pi, canine parainfluenza virus, Status: Authorised
Submitted by Anonymous (not verified) on 6 November 2024 - 16:26
Veterinary medicines European public assessment report (EPAR): Versican Plus Pi, canine parainfluenza virus, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Versican Plus L4, Canine leptospirosis vaccine (inactivated), Status: Authorised
Submitted by Anonymous (not verified) on 6 November 2024 - 16:22
Veterinary medicines European public assessment report (EPAR): Versican Plus L4, Canine leptospirosis vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Innovax-ND-IBD, Newcastle disease, infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised
Submitted by Anonymous (not verified) on 6 November 2024 - 16:10
Veterinary medicines European public assessment report (EPAR): Innovax-ND-IBD, Newcastle disease, infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised